Prosztatarák: vizsgálatok itt: Guatemala

2 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  Where

  Guatemala City

  Életkor

  18 év and over

  People

  1440 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06925737 · EU 2024-517423-40-00
• 3. fázisTaking people
  A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  Where

  Guatemala City

  Életkor

  18 év and over

  People

  1314 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06136650 · EU 2023-504957-11-00